Browsing Tag
Leerink Partners
2 posts
Biotech stocks in trouble? Immatics shares plunge after $150m funding news shocks investors
Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company focused on cancer immunotherapies, has seen its shares decline significantly…
October 10, 2024
Centessa Pharmaceuticals pulls off massive $225m deal—Stock price jumps
Centessa Pharmaceuticals has experienced a substantial rise in its share price after completing an upsized public offering of…
September 13, 2024